TOR Signaling: A central role for a region in the middle
Cellular growth is a tightly regulated process that depends on the availability of energy and nutrients. Moreover, in multicellular species, the proliferation of cells must be coordinated across tissues and organs. Protein kinases called target of rapamycin (TOR) proteins and their mammalian ortholog mTOR have a central role in growth regulation. These proteins exert their function in two complexes called TORC1 and TORC2 (or mTORC1 and mTORC2 in mammals). These complexes act as regulatory hubs that integrate input signals concerning the availability of energy and nutrients or the presence of growth factors. With their outputs, the mTOR complexes control metabolism and protein biosynthesis, and influence cell cycle progression, autophagy and cytoskeletal organization (Laplante and Sabatini, 2012; Shimobayashi and Hall, 2014).
TOR and mTOR are very large proteins (containing approximately 2300–2600 amino acids) and are members of the PIKK family of regulatory kinases. Both mTOR complexes comprise mTOR and a protein called mLST8 (Figure 1A). mTORC1 also contains a protein called Raptor, whereas mTORC2 further includes the proteins Rictor and SIN1. In both complexes, the partner proteins of mTOR determine the target specificity of the mTOR kinase (Cameron et al., 2011; Nojima et al., 2003). mTORC1 phosphorylates a diverse set of targets involved in protein biosynthesis, metabolism and transcriptional regulation, while mTORC2’s most prominent targets are regulatory kinases of the AGC family.
In mTORC1, the Raptor N-terminal conserved (RNC) domain is known to be involved in the binding of linear recognition motifs in target proteins (Dunlop et al., 2009). Recent cryo-electron microscopy studies have provided a first glimpse at its function in mTORC1 (Aylett et al., 2016). The RNC domain is well positioned in the vicinity of the kinase active site to both recognize target motifs (Beugnet et al., 2003) and to sterically prevent – in cooperation with parts of mTOR – bulky non-target proteins accessing the kinase.
However, less is known about target recognition in TORC2 and mTORC2. Now, in eLife, researchers at the Nara Institute of Science and Technology, Osaka University and the University of California, Davis -- including Hisashi Tatebe and Shinichi Murayama as joint first authors, and Tatebe and Kazuhiro Shiozaki as corresponding authors -- report the results of a series of studies on human SIN1 and its fission yeast ortholog Sin1, that shed light on the conserved role of these proteins in target binding (Tatebe et al., 2017).
SIN1 and its orthologs are known to contain four domains (Figure 1B): a variable N-terminal region (Frias et al., 2006); the ‘Conserved region in the middle’ (CRIM); an RB domain; and a PH domain. However, the role of these domains in mTORC2 target recognition remained unclear, and structural data were only available for the isolated PH domain (Pan and Matsuura, 2012). Now Tatebe et al. have clearly shown that the CRIM domain has a key role in target recognition. In particular, they demonstrated that in fission yeast, the CRIM domain in Sin1 is primarily responsible for binding targets from the AGC kinase family. In human cell lines, the CRIM domain in SIN1 is at least involved in recognition of related targets, implying an evolutionary conserved role for this domain.
Based on earlier studies (Liu et al., 2015), SIN1 may even directly interact with the mTOR kinase domain in mTORC2. Thus, SIN1 might also be positioned to restrict access of the substrate to the kinase, eventually in cooperation with Rictor, similar to Raptor in mTORC1. Tatebe et al. also highlighted the crucial role of spatial proximity in target recognition by demonstrating that fusion of only the TORC2 target-binding CRIM domain into TORC1 is sufficient to let TORC1 phosphorylate a TORC2 substrate.
Tatebe et al. also report an NMR structure for the CRIM domain in fission yeast that reveals a ubiquitin-like fold with a prominent acidic loop. Mutational analysis confirms that target binding depends on the integrity of the CRIM domain and strongly suggests that the acidic loop is involved in binding.
With the functional role and structure of the CRIM domain now firmly established, researchers can start to address the many remaining questions about TORC2 target recognition. The NMR structure of the CRIM domain provides an excellent platform for a detailed analysis of the recognition of specific motifs in target substrates by SIN1. However, studies of the overall integration of SIN1 into mTORC2 will be required to address the consequences of SIN1-target binding for subsequent phosphorylation. Finally, work on target recognition in mTOR complexes together with recent structural and functional studies on other PIKK family kinases (Sibanda et al., 2017) may reveal the presence (or absence) of common principles in target recognition across the entire PIKK family.
References
-
mTORC2 targets AGC kinases through Sin1-dependent recruitmentBiochemical Journal 439:287–297.https://doi.org/10.1042/BJ20110678
-
PtdIns(3,4,5)P3-Dependent activation of the mTORC2 kinase complexCancer Discovery 5:1194–1209.https://doi.org/10.1158/2159-8290.CD-15-0460
-
The mammalian target of rapamycin (mTOR) partner, Raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motifJournal of Biological Chemistry 278:15461–15464.https://doi.org/10.1074/jbc.C200665200
-
Structures of the pleckstrin homology domain of Saccharomyces cerevisiae Avo1 and its human orthologue Sin1, an essential subunit of TOR complex 2Acta Crystallographica Section F Structural Biology and Crystallization Communications 68:386–392.https://doi.org/10.1107/S1744309112007178
-
Making new contacts: the mTOR network in metabolism and signalling crosstalkNature Reviews Molecular Cell Biology 15:155–162.https://doi.org/10.1038/nrm3757
Article and author information
Author details
Publication history
Copyright
© 2017, Stuttfeld et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,100
- views
-
- 169
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Genetics and Genomics
Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.